A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
about
LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancerPrognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migrationDifferential expression of anterior gradient gene AGR2 in prostate cancerActive surveillance and focal therapy for low-intermediate risk prostate cancerAn Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of CholangiocarcinomaNotch signaling in prostate cancer: a moving targetThe role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision makingUnique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cellsChemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomesIdentification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urineCancer biomarker discovery: the entropic hallmark.Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancer.Integrative molecular concept modeling of prostate cancer progression.Differential expression of CD10 in prostate cancer and its clinical implicationGene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process.Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostateA novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR.Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulationMerkel cell polyomavirus is not detected in prostate cancers, surrounding stroma, or benign prostate controlsProstate cancer-associated gene expression alterations determined from needle biopsies.Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells.Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes.MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells.Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer.Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.Automated analysis of co-localized protein expression in histologic sections of prostate cancer.Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.Evaluation of ERG responsive proteome in prostate cancerGene expression pathways of high grade localized prostate cancer.MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening.Molecular genetics of prostate cancer: new prospects for old challengesTargeting monoamine oxidase A in advanced prostate cancer.Molecular pathways and targets in prostate cancerTranscriptome interrogation of human myometrium identifies differentially expressed sense-antisense pairs of protein-coding and long non-coding RNA genes in spontaneous labor at term.Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer.Loss-of-function mutations in RAB18 cause Warburg micro syndrome.mRNA expression signature of Gleason grade predicts lethal prostate cancerProtein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy
P2860
Q21202034-AB987D6C-0D06-4F0E-AE34-4DF56D7B8FECQ24617620-13F624DD-7544-47B9-B158-DC6D2DBEFCDFQ24622298-BBA375AF-87B8-4EA9-837F-FCA75368582CQ26773641-4C93AA9A-D271-4C0E-83D7-7C1DA672AAD9Q26784091-42575C41-F9A8-4D96-8850-4BB83ACEA94CQ27001047-C17803CE-BF6A-48CA-99AA-1B398256AF25Q27025062-C6A1F1CA-D1D8-40B0-8FF7-5A3FE5CC9B6CQ28391298-DD29B868-6B98-49CE-AC85-5747864E440DQ28542841-659B7068-6D13-4583-9A1A-49AD62CF25A1Q30479606-64FBD10F-7A08-49D3-8766-A080CC5BC2F6Q30496149-F56C37D1-0672-468D-ABF5-E7072E3828EAQ31049104-90C677BF-D3C7-42A8-918E-8F731ACC6FFFQ33266777-5B7B5DBB-C4B7-472E-941A-6E2AD8E82EF1Q33276668-C02E2C79-0FFF-40B9-9845-3C47D182D0DDQ33281964-4B4E8546-2059-481E-BB0D-0B32D27C2271Q33337481-88E76424-6BB2-42F7-8C31-E8BB9E9C0A6CQ33381646-1EE47F0F-C127-4635-AB5D-F91E6D4BCF50Q33390573-F004D074-0676-411C-94E6-1EE6CD755ABBQ33398259-203CD0F5-AECF-47B5-A337-205B38168D40Q33430210-23E9661C-8EEA-4706-978E-2DBC132E3F31Q33494984-08DB4AF4-2F47-4E32-897D-0CB8D0023AF4Q33519740-C39BBEA3-5873-49B3-8D62-96B98075B9D8Q33556950-DC200096-6A78-41DE-BF74-23C5517107F7Q33567270-D0634DB4-C8BB-4215-B316-42321E244C45Q33594473-5FE985B0-CACC-41DE-970F-BE3E9B7BD313Q33658285-636FE5DD-C6DA-488A-9919-B20DD3D97EF1Q33714055-D56F87CE-FFFD-4C14-BCBA-E62773BD20C4Q33732080-D23C5136-79DB-4F7F-B233-3EBA8F6012FDQ33808309-4C9B0FD3-2639-493F-A8D2-6A0592F6B11FQ33822319-BF12606A-687F-4A77-B6F1-2892AB2FC696Q33832517-042E406C-C8C6-430E-994D-9F25CDA7E6AAQ33844958-28A2C781-84B6-409B-928D-1529A48538CAQ34127462-0B7736D5-354F-49B9-8259-1EC0DA92D559Q34154664-B9654581-117D-4BD2-BEDB-8AAF93B550ADQ34365632-43CAB2B4-A1CC-4FA3-8931-3883B736A219Q34400892-306C174A-E384-48E7-A8BC-1437458596A5Q34754750-77ECA0B7-5D66-4F07-B81B-D27238D0E200Q34768417-4F9B4566-B06E-457F-BA28-83BD1BAE0C8FQ35023464-A67BAE7A-ACBF-4094-8654-E8AD0E899382Q35070161-F72791F4-7638-4DEE-BFEE-6D4C227EC24D
P2860
A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
@ast
A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
@en
A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
@nl
type
label
A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
@ast
A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
@en
A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
@nl
prefLabel
A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
@ast
A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
@en
A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
@nl
P2093
P2860
P356
P1476
A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
@en
P2093
Beatrice Knudsen
Ching-Ying Huang
Daniel Lin
David Gifford
Edward Gelmann
Elahe Mostaghel
Ilsa Coleman
Lawrence True
Milton Datta
Paul Lange
P2860
P304
10991-10996
P356
10.1073/PNAS.0603678103
P407
P50
P577
2006-07-07T00:00:00Z